Showing results (71-80 of 158) with videos related to
Sort By:
Pageof 16
Annals of the Rheumatic Diseases|May 17, 2022
Concordance and discordance in SLE clinical trial outcome measures: analysis of three anifrolumab phase 2/3 trialsIan N Bruce, Richard A Furie, Eric F Morand, et al.Annals of the Rheumatic Diseases|March 26, 2022
Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trialsEdward M Vital, Joan T Merrill, Eric F Morand, et al.The Journal of Rheumatology|May 23, 2007
Association study of Toll-like receptor 5 (TLR5) and Toll-like receptor 9 (TLR9) polymorphisms in systemic lupus erythematosusF Yesim K Demirci, Susan Manzi, Rosalind Ramsey-Goldman, et al.Arthritis and Rheumatism|February 1, 2006
Platelet C4d is highly specific for systemic lupus erythematosusJeannine S Navratil, Susan Manzi, Amy H Kao, et al.The American Journal of Cardiology|September 9, 2008
C-reactive protein and coronary artery calcium in asymptomatic women with systemic lupus erythematosus or rheumatoid arthritisAmy H Kao, Mary Chester M Wasko, Shanthi Krishnaswami, et al.Frontiers in Immunology|March 17, 2025
Multi-centered clinical validation demonstrating superior precision in lupus diagnosis: T cell autoantibodies and TC4d outperform conventional lupus erythematosus biomarkersVasileios Kyttaris, Daniel J Wallace, Arezou Khosroshahi, et al.Arthritis & Rheumatology (Hoboken, N.J.)|December 30, 2025
Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: the Randomized, Phase 3, TULIP-SC StudySusan Manzi, Ian N Bruce, Eric F Morand, et al.Stroke|October 18, 2008
Platelet C4d is associated with acute ischemic stroke and stroke severityNidhi Mehta, Ken Uchino, Saeed Fakhran, et al.The Lancet. Rheumatology|January 17, 2024
Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trialRichard A Furie, Eric F Morand, Ian N Bruce, et al.The Journal of Rheumatology|May 23, 2002
The rate and pattern of organ damage in late onset systemic lupus erythematosusPeter Maddison, Vernon Farewell, David Isenberg, et al.Pageof 16